Jacques Servier, the billionaire founder of France’s second-largest drugmaker, Les Laboratoires Servier, who late in life faced accusations of hiding information about life-threatening risks caused by a diabetes drug his companies sold, has died. He was 92.
Edwards Lifesciences Corp. and Medtronic Inc. rose in New York trading after studies were released that will increase use of their man-made valves that can be inserted into the heart without cracking open the chest.
Medtronic Inc.’s man-made aortic valve, inserted into the heart without cracking open the chest, reduced patient death rates more than open-heart surgery in the first study to ever record such a finding.
Medtronic Inc.’s CoreValve replaced damaged aortic valves more safely than expected in patients who can’t tolerate traditional open-heart surgery, leading U.S. regulators to say it won’t need an advisory committee review.